DCF — TEXAS HEALTH CLEBURNE
Enterprise Value: $-16.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-16.8M
Enterprise Value
$-7.6M
PV of Cash Flows
$-9.2M
PV of Terminal Value
$-14.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $87.5M | $0.5M | 1.0% | $-3.2M | $-2.9M |
| Year 2 | $90.1M | $1.4M | 2.0% | $-2.4M | $-2.0M |
| Year 3 | $92.8M | $2.4M | 3.0% | $-1.5M | $-1.2M |
| Year 4 | $95.6M | $3.0M | 3.0% | $-1.2M | $-0.8M |
| Year 5 | $98.5M | $3.3M | 3.0% | $-1.1M | $-0.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-16.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$84.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0008754369001857354
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5